Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation
-
Published:2017-12-20
Issue:4
Volume:38
Page:599-606
-
ISSN:0172-8172
-
Container-title:Rheumatology International
-
language:en
-
Short-container-title:Rheumatol Int
Author:
Pérez-Román Diana I.ORCID, Ortiz-Haro Ana B.ORCID, Ruiz-Medrano EmmanuelORCID, Contreras-Yáñez IrazúORCID, Pascual-Ramos VirginiaORCID
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference32 articles.
1. Vazquez-Villegas ML, Gamez-Nava JI, Celis A, Sanchez-Mosco D, de la Cerda-Trujillo LF, Murillo-Vazquez JD, Saldaña-Cruz AM, Alcaraz-Lopez MF, Diaz-Rizo V, Alvarez-Nemegyei J, Cardiel MH, Gonzalez-Lopez L (2017) Prognostic factors for permanent work disability in patients with rheumatoid arthritis who received combination therapy of conventional synthetic disease-modifying antirheumatic drugs: a retrospective cohort study. J Clin Rheumatol.
https://doi.org/10.1097/RHU.0000000000000582 2. Innala L, Sjöberg C, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2016) Comorbidity in patients with early rheumatoid arthritis—inflammation matters. Arthritis Res Ther.
https://doi.org/10.1186/s13075-016-0928-y 3. van den Hoek J, Boshuizen HC, Roorda LD, Tijhuis GJ, Nurmohamed MT, van den Bos GA, Dekker J (2017) Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 37:487–493 4. Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O’Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T (2016) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26 5. Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960–977
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|